Pliant Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | +128.1% | +67.1% | +17.7% | +17.2% | +18.8% | +1.0% | +15.4% | -20.2% | |
| – | +590.9% | +702.2% | +113.0% | +168.0% | +116.5% | +96.8% | -15.4% | -30.3% | |
| – | +590.9% | +702.2% | +127.5% | +150.8% | +116.5% | – | – | – | |
| – | +18.0% | -580.2% | – | – | -39.0% | -70.3% | +626.5% | -275.4% | |
| – | +65.3% | -58.5% | +58.9% | +27.5% | -9.9% | -47.7% | +317.8% | -90.3% | |
| – | +65.3% | +671.9% | +1,076.0% | – | -303.8% | -15.4% | – | -4.3% | |
| – | – | -44.9% | +343.1% | -98.8% | +8,433.6% | – | – | – | |
| – | – | – | +0.0% | +0.0% | +0.0% | -100.0% | – | -262.1% | |
| – | +336.6% | -47.9% | +368.2% | -98.8% | +8,877.2% | +21.0% | -91.6% | -237.1% | |
| – | +3,280.9% | -56.2% | -240.5% | – | -2,396.4% | – | -74.4% | -423.6% | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.